Zhenchuan Song

5PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 28, 2026
Independent Risk Factors and a New Nomogram for Predicting Breast Cancer Risk for Bone Metastasis in Chinese Women: A Retrospective Study with External Validation.

Yunfei Huang, Tianjiao Ge, Heng Song

|Sep 24, 2025
Eribulin plus Pyrotinib in Trastuzumab-Resistant, HER2-Positive Advanced Breast Cancer: A Single-Arm, Multicenter Phase II Trial (EPIC Trial).

Ruoyang Li, Meiqi Wang, Xiangshun Kong

|Mar 21, 2024
The Survival Benefit of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in the Management of Breast Cancer.

Ruoyang Li, Xuewei Zhao, Yunfei Huang

|Feb 28, 2024
Role of glutaminyl-peptide cyclotransferase in breast cancer doxorubicin sensitivity.

Bin Xu, Liu Yang, Lixian Yang

|Jun 16, 2023
Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer.

Bozhao Li, Feilong Qi, Fei Zhu

Pageof 1

Frequent Collaborators

3 joint publications

Meiqi Wang

1 joint publications

Bozhao Li

1 joint publications

Feilong Qi

1 joint publications

Fei Zhu